Difference between revisions of "Gail K. Naughton"
Jump to navigation
Jump to search
m (wikify skin) |
WikiModEn2 (talk | contribs) (Add inline link; add category.) |
||
| Line 1: | Line 1: | ||
| − | '''Gail K. Naughton''' was president and COO of [[Advanced Tissue Sciences]], which produced a living [[skin]] product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [ | + | '''Gail K. Naughton''' was president and COO of [[Advanced Tissue Sciences]], which produced a living [[skin]] product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [https://www.takeda.com/newsroom/newsreleases/2019/takeda-completes-acquisition-of-shire-becoming-a-global-values-based-rd-driven-biopharmaceutical-leader/ Shire], a medical company based in Dublin, Ireland. |
Naughton founded [[Histogen]] in 2007, when she was dean of {{UNI|San Diego State University|SDSU}}'s College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on [[Histogen]].<ref>{{REFweb | Naughton founded [[Histogen]] in 2007, when she was dean of {{UNI|San Diego State University|SDSU}}'s College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on [[Histogen]].<ref>{{REFweb | ||
| Line 22: | Line 22: | ||
[[Category:From CircLeaks]] | [[Category:From CircLeaks]] | ||
[[Category:From IntactWiki]] | [[Category:From IntactWiki]] | ||
| + | |||
| + | [[Category:USA]] | ||
[[de:{{FULLPAGENAME}}]] | [[de:{{FULLPAGENAME}}]] | ||
Revision as of 12:18, 4 November 2022
Gail K. Naughton was president and COO of Advanced Tissue Sciences, which produced a living skin product call Dermagraft used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of Shire, a medical company based in Dublin, Ireland.
Naughton founded Histogen in 2007, when she was dean of San Diego State University's College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on Histogen.[1]
References
- ↑
(5 September 2012). U.S. Patent issued for Histogen's Novel Cell Growth Process
, Histogen. Retrieved 16 November 2012.
